Annual Retained Earnings
-$152.44 M
-$46.51 M-43.90%
December 1, 2023
Summary
- As of February 7, 2025, CATX annual retained earnings is -$152.44 million, with the most recent change of -$46.51 million (-43.90%) on December 1, 2023.
- During the last 3 years, CATX annual retained earnings has fallen by -$61.12 million (-66.92%).
- CATX annual retained earnings is now -4389.60% below its all-time high of -$3.40 million, reached on September 1, 1994.
Performance
CATX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$191.55 M
-$15.12 M-8.57%
September 1, 2024
Summary
- As of February 7, 2025, CATX quarterly retained earnings is -$191.55 million, with the most recent change of -$15.12 million (-8.57%) on September 1, 2024.
- Over the past year, CATX quarterly retained earnings has dropped by -$63.78 million (-49.92%).
- CATX quarterly retained earnings is now -3564.21% below its all-time high of -$5.23 million, reached on September 1, 1999.
Performance
CATX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
CATX Retained Earnings Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -43.9% | -49.9% |
3 y3 years | -66.9% | -80.2% |
5 y5 years | -80.4% | -80.2% |
CATX Retained Earnings Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -66.9% | at low | -101.3% | at low |
5 y | 5-year | -80.4% | at low | -122.2% | at low |
alltime | all time | -4389.6% | +97.8% | -3564.2% | at low |
Perspective Therapeutics Retained Earnings History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | -$191.55 M(+8.6%) |
Jun 2024 | - | -$176.43 M(+7.1%) |
Mar 2024 | - | -$164.72 M(+8.1%) |
Dec 2023 | -$152.44 M(+43.9%) | -$152.44 M(+19.3%) |
Sep 2023 | - | -$127.77 M(+8.8%) |
Jun 2023 | - | -$117.41 M(+10.4%) |
Mar 2023 | - | -$106.30 M(+3.5%) |
Dec 2022 | -$105.93 M(+7.4%) | - |
Sep 2022 | - | -$102.67 M(+4.1%) |
Jun 2022 | - | -$98.60 M(+2.2%) |
Jun 2022 | -$98.60 M(+8.0%) | - |
Mar 2022 | - | -$96.52 M(+1.4%) |
Dec 2021 | - | -$95.17 M(+1.7%) |
Sep 2021 | - | -$93.57 M(+2.5%) |
Jun 2021 | -$91.33 M(+3.9%) | - |
Jun 2021 | - | -$91.33 M(+1.2%) |
Mar 2021 | - | -$90.26 M(+0.8%) |
Dec 2020 | - | -$89.52 M(+1.0%) |
Sep 2020 | - | -$88.65 M(+0.8%) |
Jun 2020 | -$87.94 M(+4.1%) | -$87.94 M(+1.4%) |
Mar 2020 | - | -$86.75 M(+0.6%) |
Dec 2019 | - | -$86.20 M(+1.1%) |
Sep 2019 | - | -$85.31 M(+1.0%) |
Jun 2019 | -$84.49 M(+6.5%) | -$84.49 M(+1.3%) |
Mar 2019 | - | -$83.40 M(+1.4%) |
Dec 2018 | - | -$82.27 M(+1.7%) |
Sep 2018 | - | -$80.86 M(+1.9%) |
Jun 2018 | -$79.35 M(+9.3%) | -$79.35 M(+3.1%) |
Mar 2018 | - | -$76.95 M(+1.8%) |
Dec 2017 | - | -$75.61 M(+2.0%) |
Sep 2017 | - | -$74.15 M(+2.1%) |
Jun 2017 | -$72.60 M(+9.3%) | -$72.60 M(+2.6%) |
Mar 2017 | - | -$70.75 M(+2.0%) |
Dec 2016 | - | -$69.39 M(+2.1%) |
Sep 2016 | - | -$67.94 M(+2.3%) |
Jun 2016 | -$66.44 M(+7.6%) | -$66.44 M(+1.8%) |
Mar 2016 | - | -$65.26 M(+1.9%) |
Dec 2015 | - | -$64.06 M(+2.1%) |
Sep 2015 | - | -$62.75 M(+1.7%) |
Jun 2015 | -$61.73 M(+6.3%) | -$61.73 M(+1.7%) |
Mar 2015 | - | -$60.70 M(+1.6%) |
Dec 2014 | - | -$59.74 M(+1.5%) |
Sep 2014 | - | -$58.84 M(+1.4%) |
Jun 2014 | -$58.05 M(+11.4%) | -$58.05 M(+3.0%) |
Mar 2014 | - | -$56.37 M(+3.8%) |
Dec 2013 | - | -$54.29 M(+1.7%) |
Sep 2013 | - | -$53.36 M(+2.4%) |
Jun 2013 | -$52.09 M(+8.0%) | -$52.09 M(+1.9%) |
Mar 2013 | - | -$51.10 M(+1.4%) |
Dec 2012 | - | -$50.38 M(+2.3%) |
Sep 2012 | - | -$49.23 M(+2.1%) |
Jun 2012 | -$48.23 M | -$48.23 M(+2.6%) |
Mar 2012 | - | -$47.03 M(+1.2%) |
Dec 2011 | - | -$46.48 M(+1.4%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2011 | - | -$45.85 M(+2.5%) |
Jun 2011 | -$44.75 M(+6.8%) | -$44.75 M(+1.6%) |
Mar 2011 | - | -$44.03 M(+2.4%) |
Dec 2010 | - | -$43.00 M(+0.5%) |
Sep 2010 | - | -$42.78 M(+2.1%) |
Jun 2010 | -$41.90 M(+10.7%) | -$41.90 M(+2.7%) |
Mar 2010 | - | -$40.82 M(+2.8%) |
Dec 2009 | - | -$39.73 M(+2.4%) |
Sep 2009 | - | -$38.78 M(+2.4%) |
Jun 2009 | -$37.87 M(+19.4%) | -$37.87 M(+3.4%) |
Mar 2009 | - | -$36.62 M(+4.2%) |
Dec 2008 | - | -$35.14 M(+4.9%) |
Sep 2008 | - | -$33.50 M(+5.7%) |
Jun 2008 | -$31.71 M(+37.0%) | -$31.71 M(+4.8%) |
Mar 2008 | - | -$30.27 M(+7.7%) |
Dec 2007 | - | -$28.10 M(+11.0%) |
Sep 2007 | - | -$25.31 M(+9.3%) |
Jun 2007 | -$23.15 M(+70.9%) | -$23.15 M(+13.4%) |
Mar 2007 | - | -$20.42 M(+11.0%) |
Dec 2006 | - | -$18.39 M(+11.6%) |
Sep 2006 | - | -$16.47 M(+21.6%) |
Jun 2006 | -$13.55 M(-99.8%) | -$13.55 M(+24.0%) |
Mar 2006 | - | -$10.93 M(+17.9%) |
Dec 2005 | - | -$9.27 M(+27.2%) |
Sep 2005 | - | -$7.29 M(+4.6%) |
Jun 2005 | -$6.99 B(>+9900.0%) | - |
Mar 2005 | - | -$6.97 M(-4.2%) |
Dec 2004 | - | -$7.27 M(+0.0%) |
Sep 2004 | -$7.27 M(-1.0%) | -$7.27 M(+0.1%) |
Jun 2004 | - | -$7.26 M(-1.2%) |
Mar 2004 | - | -$7.36 M(+0.1%) |
Dec 2003 | - | -$7.35 M(+0.1%) |
Sep 2003 | -$7.34 M(+0.8%) | -$7.34 M(+0.1%) |
Jun 2003 | - | -$7.33 M(+0.2%) |
Mar 2003 | - | -$7.32 M(+0.2%) |
Dec 2002 | - | -$7.30 M(+0.3%) |
Sep 2002 | -$7.28 M(+0.8%) | -$7.28 M(+0.2%) |
Jun 2002 | - | -$7.27 M(+0.2%) |
Mar 2002 | - | -$7.26 M(+0.2%) |
Dec 2001 | - | -$7.24 M(+0.2%) |
Sep 2001 | -$7.23 M(-3.2%) | -$7.23 M(-3.8%) |
Jun 2001 | - | -$7.51 M(+0.3%) |
Mar 2001 | - | -$7.49 M(+0.2%) |
Dec 2000 | - | -$7.48 M(+0.2%) |
Sep 2000 | -$7.46 M(+42.7%) | -$7.46 M(+0.4%) |
Jun 2000 | - | -$7.43 M(+0.2%) |
Mar 2000 | - | -$7.42 M(+41.6%) |
Dec 1999 | - | -$5.24 M(+0.2%) |
Sep 1999 | -$5.23 M(-25.9%) | -$5.23 M |
Sep 1998 | -$7.05 M(+2.0%) | - |
Sep 1997 | -$6.91 M(+6.6%) | - |
Sep 1996 | -$6.49 M(+49.6%) | - |
Sep 1995 | -$4.33 M(+27.7%) | - |
Sep 1994 | -$3.40 M | - |
FAQ
- What is Perspective Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Perspective Therapeutics?
- What is Perspective Therapeutics annual retained earnings year-on-year change?
- What is Perspective Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Perspective Therapeutics?
- What is Perspective Therapeutics quarterly retained earnings year-on-year change?
What is Perspective Therapeutics annual retained earnings?
The current annual retained earnings of CATX is -$152.44 M
What is the all time high annual retained earnings for Perspective Therapeutics?
Perspective Therapeutics all-time high annual retained earnings is -$3.40 M
What is Perspective Therapeutics annual retained earnings year-on-year change?
Over the past year, CATX annual retained earnings has changed by -$46.51 M (-43.90%)
What is Perspective Therapeutics quarterly retained earnings?
The current quarterly retained earnings of CATX is -$191.55 M
What is the all time high quarterly retained earnings for Perspective Therapeutics?
Perspective Therapeutics all-time high quarterly retained earnings is -$5.23 M
What is Perspective Therapeutics quarterly retained earnings year-on-year change?
Over the past year, CATX quarterly retained earnings has changed by -$63.78 M (-49.92%)